Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pneumococcal vaccine - GPN Vaccines

Next Previous
Drug Profile

Pneumococcal vaccine - GPN Vaccines

Alternative Names: Gamma-PN3 - GPN Vaccines; Gamma-PNTM - GPN Vaccines; S. pneumoniae vaccine - GPN Vaccines; Spn vaccine - GPN Vaccines; Streptococcus pneumoniae vaccine - GPN Vaccines

Latest Information Update: 30 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Gamma Vaccines; University of Adelaide
  • Developer Gamma Vaccines
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Pneumococcal infections

Most Recent Events

  • 31 Mar 2025 GPN Vaccines completes phase-I clinical trials in Pneumococcal infections (In the elderly, Prevention) in Australia (IM) (NCT06562790)
  • 04 Oct 2024 Preclinical development is ongoing in Pneumococcal-infections(Prevention) in Australia (Intranasal) (GPN Vaccines pipeline, October 2024)
  • 30 Aug 2024 GPN Vaccines completes a phase I/II trial in Pneumococcal infections (In the elderly, Prevention, In adults) in Australia (unspecified route) (NCT05982314)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top